Stockreport

Axsome Therapeutics Highlights Auvelity Momentum, 600-Rep Sales Push, and April 30 ADA PDUFA at Oppenheimer Conf. [Yahoo! Finance]

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com
PDF Axsome Therapeutics logo Key Points Auvelity commercial momentum: Axsome is expanding its U.S. sales force from ~300 to a planned 600 reps to drive primary-care pen [Read more]